Cargando…
Molecular basis of human CD22 function and therapeutic targeting
CD22 maintains a baseline level of B-cell inhibition to keep humoral immunity in check. As a B-cell-restricted antigen, CD22 is targeted in therapies against dysregulated B cells that cause autoimmune diseases and blood cancers. Here we report the crystal structure of human CD22 at 2.1 Å resolution,...
Autores principales: | Ereño-Orbea, June, Sicard, Taylor, Cui, Hong, Mazhab-Jafari, Mohammad T., Benlekbir, Samir, Guarné, Alba, Rubinstein, John L., Julien, Jean-Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624926/ https://www.ncbi.nlm.nih.gov/pubmed/28970495 http://dx.doi.org/10.1038/s41467-017-00836-6 |
Ejemplares similares
-
N-Linked Glycosylation Regulates CD22 Organization and Function
por: Wasim, Laabiah, et al.
Publicado: (2019) -
Structural details of monoclonal antibody m971 recognition of the membrane-proximal domain of CD22
por: Ereño-Orbea, June, et al.
Publicado: (2021) -
Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
por: Ereño-Orbea, June, et al.
Publicado: (2018) -
Current Status on Therapeutic Molecules Targeting Siglec Receptors
por: Lenza, María Pia, et al.
Publicado: (2020) -
Cryo-EM studies of the structure and dynamics of vacuolar-type ATPases
por: Mazhab-Jafari, Mohammad T., et al.
Publicado: (2016)